v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
 [1]
Current Assets    
Cash and cash equivalents $ 11,400 $ 537,100
Accounts receivable, net of allowance for credit losses of $24,200 and $24,200, respectively 992,700 591,000
Inventory 2,100 2,100
Contract assets 21,500
Prepaid expenses and other current assets 317,400 102,600
Assets held for sale
Total Current Assets 1,345,100 1,232,800
Property and equipment, net 41,900 44,000
Intangible Assets, net 14,100 14,700
Right of use assets 114,600 126,200
Other assets 40,000 40,000
TOTAL ASSETS 1,555,700 1,457,700
Current Liabilities    
Accounts payable 1,463,200 905,000
Accrued liabilities 4,975,000 4,756,700
Contract liabilities 1,149,400 1,129,600
Deferred revenue 20,600 20,600
Short term notes 4,771,600 5,248,100
Short term notes and accrued interest - related party 227,400 220,100
Convertible notes 1,605,000 1,605,000
Current portion of long-term debt and finance lease obligations 505,700 506,500
Current portion of lease liabilities 72,500 72,500
Liabilities held for sale 34,500 34,500
Total Current Liabilities 14,824,900 14,498,600
Lease liabilities net of current portion 60,000 72,900
Long term debt 1,836,500 1,838,000
Total Liabilities 16,721,400 16,409,500
Commitments and contingencies
Stockholders’ deficit    
Preferred stock; $.001 par value; 5,000,000 shares authorized; -0- shares issued 4,000
Common stock; $.001 par value; 320,000,000 shares authorized; 68,688,575 shares issued, issuable* and outstanding March 31, 2025 and 70,000,000 shares authorized on December 31, 2024 68,700 65,100
Common stock issuable 25,000 25,000
Additional paid-in capital 23,347,800 23,113,800
Stock Subscription receivable (25,000) (25,000)
Accumulated deficit (36,627,300) (36,180,700)
Total stockholders’ deficit (13,210,800) (12,997,800)
Non-controlling interest (1,954,900) (1,954,000)
Total Deficit (15,165,700) (14,951,800)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 1,555,700 $ 1,457,700
[1] These numbers are derived from the audited financial statements for the year ended December 31, 2024.